New England Capital Financial Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1
| Closed | -$48 | – | 402 |
|
|
2024
Q4 | $48 | Hold |
1
| – | – | ﹤0.01% | 406 |
|
|
2024
Q3 | $53 | Hold |
1
| – | – | ﹤0.01% | 393 |
|
|
2024
Q2 | $55 | Hold |
1
| – | – | ﹤0.01% | 398 |
|
|
2024
Q1 | $71 | Hold |
1
| – | – | ﹤0.01% | 391 |
|
|
2023
Q4 | $84 | Hold |
1
| – | – | ﹤0.01% | 392 |
|
|
2023
Q3 | $30 | Hold |
1
| – | – | ﹤0.01% | 392 |
|
|
2023
Q2 | $33 | Hold |
1
| – | – | ﹤0.01% | 388 |
|
|
2023
Q1 | $36 | Hold |
1
| – | – | ﹤0.01% | 431 |
|
|
2022
Q4 | $42 | Buy |
+1
| New | +$42 | ﹤0.01% | 435 |
|